Skip to main content
NewslettersWatchlist

Laboratory Corp of America Holdings(LH-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low199.65
Day High201.32
Open:200.73
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
The Globe and Mail
17 U.S. stocks that may benefit from eventual easing in interest rates
Motley Fool
Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today
Stock Picking, Options Trading for Income
October 2023 Cash Secured Puts Trades Update #2
PR Newswire
Labcorp Declares Quarterly Dividend
PR Newswire
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
PR Newswire
LABCORP AND BAYSTATE HEALTH ANNOUNCE STRATEGIC RELATIONSHIP FOR DIAGNOSTIC LABORATORY SERVICES
PR Newswire
Labcorp to Announce Third Quarter Financial Results on October 26, 2023
Stock Picking, Options Trading for Income
10 October 2023 Puts Options Trades
PR Newswire
Labcorp to Present Strategy, Business and Financial Outlook at Investor Day
PR Newswire
Labcorp to Host Investor Day on September 14, 2023
PR Newswire
Labcorp Announces 2023 Second Quarter Results
PR Newswire
Labcorp OnDemand Offers Menopause Test to Consumers
PR Newswire
Labcorp Declares Quarterly Dividend
PR Newswire
LABCORP AND LEGACY HEALTH AGREE TO COMPREHENSIVE LABORATORY RELATIONSHIP
Motley Fool
Why Shares of Labcorp Dropped Monday
PR Newswire
Labcorp Completes Spin-off of Fortrea
PR Newswire
Labcorp to Announce Second Quarter Financial Results on July 27, 2023
PR Newswire
Fortrea Holdings and PHINIA Set to Join S&P SmallCap 600
PR Newswire
LABCORP ANNOUNCES PRICING OF FORTREA $570 MILLION NOTES OFFERING IN CONNECTION WITH ANTICIPATED FORTREA SPINOFF
PR Newswire
LABCORP ANNOUNCES ADDITIONAL INFORMATION IN CONNECTION WITH ITS SPIN-OFF OF FORTREA
PR Newswire
Labcorp Announces Information in Connection with its Spin-off of Fortrea
PR Newswire
Labcorp Announces Launch of Fortrea's Notes Offering in Connection with Anticipated Spinoff
PR Newswire
Labcorp Appoints Dr. Paul Rothman to Board of Directors
PR Newswire
Labcorp's Planned Spin-off, Fortrea, to Host 2023 Investor Day
PR Newswire
Labcorp Plasma Focus™ Liquid Biopsy Test Now Available
Motley Fool
3 No-Brainer Stocks to Buy in a Correction
PR Newswire
Labcorp and Providence Expand Strategic Laboratory Relationship
MarketBeat
Exact Sciences Serves Investors Exactly What They Wished For
PR Newswire
LABCORP TO WEBCAST ITS ANNUAL MEETING OF SHAREHOLDERS
Business Wire
Forge Biologics and Labcorp Announce Strategic AAV Gene Therapy Development and Manufacturing Collaboration
PR Newswire
LABCORP AND JEFFERSON HEALTH ANNOUNCE STRATEGIC LABORATORY RELATIONSHIP
PR Newswire
SHAREHOLDER ALERT: Weiss Law Investigates Enzo Biochem, Inc.

Profile

Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.